Rosehip powder could be just as effective as NSAIDs in reducing osteoarthritis-related pain, new research has found.
A review of several studies, published in the July edition of Australian Family Physician
, suggests rosehip could be a viable alternative to more commonly used anti-inflammatory drugs, which have been linked to gastrointestinal and cardiovascular problems in at risk users.
“In contrast to nonsteroidal anti-inflammatory drugs (NSAIDs) and aspirin, rosehip has anti-inflammatory actions that do not have ulcerogenic effects and do not inhibit platelets or influence the coagulation cascade or fibrinolysis, thereby avoiding potential side effects,” said study author, Professor Marc Cohen, of RMIT University, Victoria.
The paper looked at the results of three randomised controlled trials which showed patients who took rosehip were twice as likely to report reduced pain scores than those who took a placebo.
Rosehip also reduced pain in 64.6 per cent of 100 trialled patients with knee or hip osteoarthritis.
It’s believed the substance has a number of other positive benefits, including reducing blood glucose levels and inhibiting weight gain and cholesterol storage, Professor Cohen said.
But “further research is required to establish (rosehip’s) clinical role.”
“While these activities are promising, they await further confirmation in large human clinical trials.”